Anna Zygogianni

Prof. Dr. Anna Zygogianni


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2011 in Head & Neck Oncology
Verified
Journal Article
Open access
PDF file
AZAnna Zygogianni
Anna Zygogianni
GKGeorge Kyrgias
George Kyrgias
PKPetros Karakitsos
Petros Karakitsos
APAmanta Psyrri
Amanta Psyrri
JKJohn Kouvaris
John Kouvaris
Vassilis KoulouliasVassilis Kouloulias
Vassilis Kouloulias
Oral squamous cell carcinoma has a remarkable incidence worldwide and a fairly onerous prognosis, encouraging further research on factors that might modify disease outcome. A web-based search for all types of articles published was initiated using Medline/Pub Med, with the key words such as oral cancer, alcohol consumption, genetic polymorphisms, tobacco smoking and prevention. The search was restricted to articles published in English, with no publication date restriction (last update 2010). In this review article, we approach the factors for a cytologic diagnosis during OSCC development and the markers used in modern diagnostic technologies as well. We also reviewed available studies of the combined effects of alcohol drinking and genetic polymorphisms on alcohol-related cancer risk. The interaction of smoking and alcohol significantly increases the risk for aero-digestive cancers. The interaction between smoking and alcohol consumption seems to be responsible for a significant amount of disease. Published scientific data show promising pathways for the future development of more effective prognosis. There is a clear need for new prognostic indicators, which could be used in diagnostics and, therefore a better selection of the most effective treatment can be achieved.

5 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
IGIoannis Georgakopoulos
Ioannis Georgakopoulos
Vassilis KoulouliasVassilis Kouloulias
Vassilis Kouloulias
GNGeorgios Nikiforos Ntoumas
Georgios Nikiforos Ntoumas
DDDimitra Desse
Dimitra Desse
IKIOANNIS KOUKOURAKIS
IOANNIS KOUKOURAKIS
AZAnna Zygogianni
Anna Zygogianni
This comprehensive review explores the existing literature on the effects of radiotherapy on testicular function, focusing mainly on spermatogenic effects, but also with a brief report on endocrine abnormalities. Data from animal experiments as well as results on humans either from clinical studies or from accidental radiation exposure are included to demonstrate a complete perspective on the level of vulnerability of the testes and their various cellular components to irradiation. Even relatively low doses of radiation, produced either from direct testicular irradiation or more commonly from scattered doses, may often lead to detrimental effects on sperm count and quality. Leydig cells are more radioresistant; however, they can still be influenced by the doses used in clinical practice. The potential resultant fertility complications of cancer radiotherapy should be always discussed with the patient before treatment initiation, and all available and appropriate fertility preservation measures should be taken to ensure the future reproductive potential of the patient. The topic of potential hereditary effects of germ cell irradiation remains a controversial field with ethical implications, requiring future research.

Verified
Journal Article
Open access
PDF file
IKIOANNIS KOUKOURAKIS
IOANNIS KOUKOURAKIS
Kalliopi-Pola PlatoniKalliopi-Pola Platoni
Kalliopi-Pola Platoni
Vassilis KoulouliasVassilis Kouloulias
Vassilis Kouloulias
SAStella Arelaki
Stella Arelaki
AZAnna Zygogianni
Anna Zygogianni
Stem cells differentiate into mature organ/tissue-specific cells at a steady pace under normal conditions, but their growth can be accelerated during the process of tissue healing or in the context of certain diseases. It is postulated that the proliferation and growth of carcinomas are sustained by the presence of a vital cellular compartment resembling stem cells residing in normal tissues: ‘stem-like cancer cells’ or cancer stem cells (CSCs). Mutations in prostate stem cells can lead to the formation of prostate cancer. Prostate CSCs (PCSCs) have been identified and partially characterized. These express surface markers include CD44, CD133, integrin α2β1, and pluripotency factors like OCT4, NANOG, and SOX2. Several signaling pathways are also over-activated, including Notch, PTEN/Akt/PI3K, RAS-RAF-MEK-ERK and HH. Moreover, PCSCs appear to induce resistance to radiotherapy and chemotherapy, while their presence has been linked to aggressive cancer behavior and higher relapse rates. The development of treatment policies to target PCSCs in tumors is appealing as radiotherapy and chemotherapy, through cancer cell killing, trigger tumor repopulation via activated stem cells. Thus, blocking this reactive stem cell mobilization may facilitate a positive outcome through cytotoxic treatment.

31 January 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
AZAnna Zygogianni
Anna Zygogianni
GKGeorge Kyrgias
George Kyrgias
CGCostantinos Gennatas
Costantinos Gennatas
AIAytas Ilknur
Aytas Ilknur
VAVassilios Armonis
Vassilios Armonis
VKVassilios Kouloulias
Vassilios Kouloulias
Male Breast Carcinoma: Epidemiology, Risk Factors and Current Therapeutic Approaches Male breast cancer;epidemiology;treatment;review; Male breast cancer is a very rare disease with an incidence of about 0.5-1% comparing with the one of female breast cancer but relatively little is known about its cause. Treatment strategies for breast cancer in males are derived from studies performed among females. The probable reasons behind the frequent, late diagnoses presented at stages III or IV might be the lack of awareness. The rarity of the disease precludes large prospective randomized clinical trials. This study reviews male breast cancer and its risk factors, recommendations for diagnosis and the management of patients with male breast cancer.

16 October 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
MPMichalis Psarras
Michalis Psarras
DSDespoina Stasinou
Despoina Stasinou
TSTheodoros Stroubinis
Theodoros Stroubinis
MPMaria Protopapa
Maria Protopapa
AZAnna Zygogianni
Anna Zygogianni
Kalliopi-Pola PlatoniKalliopi-Pola Platoni
Kalliopi-Pola Platoni
The surface-guided radiotherapy (SGRT) technique improves patient positioning with submillimeter accuracy compared with the conventional positioning technique of lasers using three-point tattoos. SGRT provides solutions to considerations that arise from the conventional setup technique, such as variability in tattoo position and the psychological impact of the tattoos. Moreover, SGRT provides monitoring of intrafractional motion. Purpose: This literature review covers the basics of SGRT systems and examines whether SGRT can replace the traditional positioning technique. In addition, it investigates SGRT’s potential in reducing positioning times, factors affecting SGRT accuracy, the effectiveness of live monitoring, and the impact on patient dosage. Materials and Methods: This study focused on papers published from 2016 onward that compared SGRT with the traditional positioning technique and investigated factors affecting SGRT accuracy and effectiveness. Results/Conclusions: SGRT provides the same or better results regarding patient positioning. The implementation of SGRT can reduce overall treatment time. It is an effective technique for detecting intrafraction patient motion, improving treatment accuracy and precision, and creating a safe and comfortable environment for the patient during treatment.

22 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
VIVASILIKI ILIADOU
VASILIKI ILIADOU
Ioannis KakkosIoannis Kakkos
Ioannis Kakkos
PKPantelis Karaiskos
Pantelis Karaiskos
Vassilis KoulouliasVassilis Kouloulias
Vassilis Kouloulias
Kalliopi-Pola PlatoniKalliopi-Pola Platoni
Kalliopi-Pola Platoni
George K. MatsopoulosGeorge K. Matsopoulos
George K. Matsopoulos
Background: During RT cycles, the tumor response pattern could affect tumor coverage and may lead to organs at risk of overdose. As such, early prediction of significant volumetric changes could therefore reduce potential radiation-related adverse effects. Nevertheless, effective machine learning approaches based on the radiomic features of the clinically used CBCT images to determine the tumor volume variations due to RT not having been implemented so far. Methods: CBCT images from 40 HN cancer patients were collected weekly during RT treatment. From the obtained images, the Clinical Target Volume (CTV) and Parotid Glands (PG) regions of interest were utilized to calculate 104 delta-radiomics features. These features were fed on a feature selection and classification procedure for the early prediction of significant volumetric alterations. Results: The proposed framework was able to achieve 0.90 classification performance accuracy while detecting a small subset of discriminative characteristics from the 1st week of RT. The selected features were further analyzed regarding their effects on temporal changes in anatomy and tumor response modeling. Conclusion: The use of machine learning algorithms offers promising perspectives for fast and reliable early prediction of large volumetric deviations as a result of RT treatment, exploiting hidden patterns in the overall anatomical characteristics.